comparemela.com
  1. Home
  2. Live Updates
  3. Mario Perro - Breaking News

Mario Perro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ICHNOS SCIENCES PRESENTS DATA SUPPORTING THREE ONCOLOGY ASSETS AT ASH 2022 ANNUAL MEETING

/PRNewswire/ Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific immune cell engager antibodies in.

New yorkUnited statesTony jiangMario perroSanjay mohanCyril kontoStefano sammicheliAmerican society of hematologyHead of communicationsPrnewswire ichnos sciences incIchnos sciencesIchnos sciences incCorporate affairsOncology research at ichnos sciencesSciences incAmerican society

ICHNOS SCIENCES PRESENTS PRECLINICAL DATA ON NOVEL ISB 1442 IN RELAPSED/REFRACTORY MULTIPLE MYELOMA AT THE ASH 2021 ANNUAL MEETING

/PRNewswire/ Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology, today presented preclinical data that support.

New yorkUnited statesMario perroCyril kontoStefano sammicheliAmerican society of hematologyHead of communicationsPrnewswire ichnos sciences incIchnos sciences incIchnos sciencesCorporate affairsSciences incInnate cell engagersAmerican societyVice president oncologyInterim head

ICHNOS SCIENCES PRESENTS PRECLINICAL DATA ON NOVEL ISB 1442 IN RELAPSED/REFRACTORY MULTIPLE MYELOMA AT THE ASH 2021 ANNUAL MEETING

/PRNewswire/ Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology, today presented preclinical data that support.

New yorkUnited statesMario perroCyril kontoStefano sammicheliAmerican society of hematologyHead of communicationsPrnewswire ichnos sciences incIchnos sciences incIchnos sciencesCorporate affairsSciences incInnate cell engagersAmerican societyVice president oncologyInterim head

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.